10 September 2006

Contents

Conference reports

• Enough is enough: South African activists demand: fire Manto

• Treatment access: more optimistic results from scale up programmes

• Integrase inhibitor MK-0518: early results show greater early potency than efavirenz

• Maraviroc results in R5/X4 mixed/dual tropic patients: unexpected safety data shows possible immunolocical effect

• Vicriviroc 24-week results in triple-class experienced R5-tropic patients